Nigeria

in page functions
[French]
Total population (2016) 186,987,534
Birth cohort (2016) 7,228,038
Surviving Infants (surviving to 1 year per year, 2016) 6,723,210
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 69/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 109/1000
World Bank Index, IDA (2012) 3.44
Co-financing status (2016) Preparatory transition
No. of districts/territories (2015) 774

Gavi support for Nigeria

Type of support

Approvals

2001-2020 (US$)
(22 Jul 2016)

Commitments

2001-2020 (US$)
(22 Jul 2016)

Disbursements

2000-2016 (US$)
(22 Jul 2016)

% Disbursed

(22 Jul 2016)
2001 2002 2003 2004 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Health system strengthening (HSS 1) $42,504,000 $42,504,000 $40,238,758 95%
Immunisation services support (ISS) $47,324,000 $47,324,000 $47,324,000 100%
Injection safety support (INS) $12,630,270 $12,630,270 $12,610,218 100%
IPV (NVS) $21,671,374 $29,654,874 $19,456,081 90%
Measles SIA (NVS) $22,491,870 $22,491,870 $23,749,980 106%
Measles SIA - Operational costs (OPC) $39,423,500 $39,423,500 $39,423,500 100%
Meningitis A - campaign (NVS) $55,966,777 $55,966,777 $56,057,711 100%
Meningitis A - operational costs (OPC) $43,505,648 $43,505,648 $43,505,648 100%
Penta (NVS) $138,808,841 $138,808,841 $125,942,892 91%
Pneumo (NVS) $144,740,500 $144,740,500 $87,958,802 61%
Vaccine Introduction Grant (VIG) $15,861,921 $15,861,921 $14,176,839 89%
Yellow Fever (NVS) $39,012,946 $39,012,946 $39,711,793 102%
Yellow Fever - campaign (NVS) $32,627,883 $32,627,883 $18,220,556 56%
YF - Operational costs (OPC) $18,571,500 $18,571,500 $6,495,000 35%
Total $675,141,030 $683,124,530 $574,871,778

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Nigeria DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 74%
M:F sex ratio at birth (2016) 1.06
Household survey: DTP3 coverage for male (2012) 39.40%
Household survey: DTP3 coverage for female (2012) 37.00%
Household survey: Last DTP3 survey (2012) 38%
% districts achieving > 80% DTP3 coverage (2015) 80%
% districts achieving < 50% DTP3 coverage (2015) 2%
MCV WHO/UNICEF estimates (2015) 54%

Breakdown of support

Non-vaccine support Vaccine support
35% 65%
$203,773,961 $371,097,811

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Nigeria

27 July 2016

First Sudanese child to receive Meningitis A vaccine as part of routine immunization.

Sudan: first to introduce life-saving meningitis A vaccine into routine immunization

Children in Sudan are set to become the first in the Meningitis belt to benefit from the introduction of Meningitis A vaccine into a routine immunization programme.

25 February 2016

MCIA logo graphic

African Ministers pledge to improve access to vaccines

First-ever Ministerial Conference on Immunization in Africa delivers concludes with signed declaration to promote the use of vaccines across the African continent.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

close icon

modal window here